top of page

Innately curing cancer with Immuno-Modulatory Alpha Neutrophils (IMANs)

Developing affordable curative cell therapies for solid tumours with high unmet medical need.

​Our IMANs are the ultimate cancer immuno-surveillance cell. We have designed them with a unique dual mechanism-of-action that both directly kills cancer cells, and recruits and modulates the rest of the immune system to identify tumours and destroy them.

Company

LIfT BioSciences
London BioScience Innovation Centre

2 Royal College Street,
London,
England,

NW1 0NH
United Kingdom,

Company Reg: 09277638

  • LIfTBio on Facebook
  • X
  • CEO's Linked-in
Quick Links

 

Copyright © 2024 LIfT BioSciences Ltd. All Rights Reserved.

bottom of page